Nektar Therapeutics (NKTR) Q2 2025 Earnings

8MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-3.6
-2.39
-1.18
0.03

Details

Expected EPS
-2.56425
Actual EPS
-3.6
Surprise EPS
-1.04
Surprise Percent
+40.39%

Description

Nektar Therapeutics (NKTR) has reported earnings of -3.6 per share for Q2 2025.

0 Comments

Share your thoughts